NRAS-mutations have been reported with a frequency of <1% in NSCLC, most commonly in association with adenocarcinoma histology and tobacco exposure, in analogy with KRAS-mutations [151]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.